| Mr Marshall H Lewis, LMLP, LCP | |
|
1145 E Kansas Plz, Garden City, KS 67846-5870 | |
| (620) 275-0625 | |
| (620) 275-7908 |
| Full Name | Mr Marshall H Lewis |
|---|---|
| Gender | Male |
| Speciality | Psychologist |
| Location | 1145 E Kansas Plz, Garden City, Kansas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1740231794 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103T00000X | Psychologist | LMLP 0070 (Kansas) | Secondary |
| 103T00000X | Psychologist | LCP 088 (Kansas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mr Marshall H Lewis, LMLP, LCP 1145 E Kansas Plz, Garden City, KS 67846-5870 Ph: (620) 275-0625 | Mr Marshall H Lewis, LMLP, LCP 1145 E Kansas Plz, Garden City, KS 67846-5870 Ph: (620) 275-0625 |
News Archive
When cancers metastasize, cells from the primary tumor break away, travel through the blood or lymph system, and form new tumors in other body parts. Although metastasis are responsible for more than 90% of all cancer deaths, limited progress has been made in treating cancers that have spread.
Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that the company is set to be added to the broad-market Russell 3000® Index when Russell Investments reconstitutes its comprehensive set of U.S. and global equity indexes on June 25, according to a preliminary list of additions updated on June 18 on www.russell.com.
Mayo Clinic researchers have shown that an immunosuppressive drug used in organ transplant cases is effective in reducing flare-ups in patients with systemic lupus erythematosus (SLE)
The U.S. Food and Drug Administration has scheduled a meeting of its Vaccines and Related Biological Products Advisory Committee (VRBPAC) on Dec. 10 to discuss the request for emergency use authorization (EUA) of a COVID-19 vaccine from Pfizer, Inc. in partnership with BioNTech Manufacturing GmbH.
Hyperfine Research Inc. announced today its collaboration with the Yale School of Medicine to pioneer the use of the world's first portable, low-cost magnetic resonance imaging system at the bedside of patients in the neuro intensive care unit of Yale New Haven Hospital. Hyperfine's system can move directly to the bedside, plug into a wall outlet, and operate in any healthcare setting.
› Verified 3 days ago
Lisa M Southern, LMLP, LCP Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1145 E Kansas Plz, Garden City, KS 67846 Phone: 620-275-0625 Fax: 620-275-7908 | |
Max E Meschberger, LMLP, LCP, LCMFT Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1145 E Kansas Plz, Garden City, KS 67846 Phone: 620-275-0625 Fax: 620-275-7908 | |
Anthony L Snow, LMLP, LCP Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1145 E Kansas Plz, Garden City, KS 67846 Phone: 620-275-0625 Fax: 620-275-7908 | |
Monserrat Feria-vargas, Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1111 E Spruce St, Garden City, KS 67846 Phone: 620-276-7689 | |
Ms. Teresa Rene Sutherlin, LCP Psychologist Medicare: Not Enrolled in Medicare Practice Location: 531 Campus View St, Garden City, KS 67846 Phone: 620-275-0644 Fax: 620-272-0239 | |
Melissa Rose Parker, LMLP Psychologist Medicare: Not Enrolled in Medicare Practice Location: 531 Campus View St, Garden City, KS 67846 Phone: 620-275-0644 Fax: 620-272-0239 |